Home/Filings/4/A/0000950103-24-000615
4/A//SEC Filing

Ponessa Sara 4/A

Accession 0000950103-24-000615

CIK 0001977303other

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 10:39 AM ET

Size

9.0 KB

Accession

0000950103-24-000615

Insider Transaction Report

Form 4/AAmended
Period: 2024-01-04
Ponessa Sara
General Counsel, VP & Sec
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-01-04+64,16064,160 total
    Exercise: $7.07From: 2021-10-10Exp: 2028-10-10Ordinary Shares (64,160 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-01-04+64,16064,160 total
    Exercise: $7.07From: 2022-10-10Exp: 2028-10-10Ordinary Shares (64,160 underlying)
Footnotes (2)
  • [F1]The original Form 4, filed on January 8, 2024, is being amended by this Form 4 amendment to correct an error which omitted these tranches from the list of stock options to purchase common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Options") beneficially owned by the reporting person as of January 4, 2024 and converted in accordance with the terms of the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction (as amended, the "Transaction Agreement")
  • [F2]Represents the conversion of Livent Options into stock options to purchase ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 per share ("Arcadium Options"), in accordance with the terms of the Transaction Agreement, in connection with the merger of equals transaction.

Issuer

Arcadium Lithium plc

CIK 0001977303

Entity typeother

Related Parties

1
  • filerCIK 0001752727

Filing Metadata

Form type
4/A
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 10:39 AM ET
Size
9.0 KB